While you’re here… help us stay here.

As we confront the economic impacts of the pandemic, we need your support even more. So that we can continue to bring you the latest in policy and research, please donate to APO.

Clinical trials


+AllTrials Transparency Index

The AllTrials Transparency Index ranks all the world’s major drug companies, and a selection of smaller firms, by the commitments they make to clinical trials transparency.

Economic evaluation of investigator-initiated clinical trials conducted by networks: final report

This report analysed 25 Australian clinical trials initiated by clinicians and found that if the results of the trials were implemented in just two-thirds of the relevant groups of patients for one year, $1.4 billion would be saved through improvements in patient health outcomes, and...

Report on the forum on a national approach to clinical trials

The Forum brought together a broad cross-section of stakeholders involved in conducting clinical trials, including those agencies already working on a national approach, industry, researchers, ethics committee representatives, a patient group advocate and industry/state development departments. The aim of the Forum was to enhance the...